Cargando…
High-resolution structural information of membrane-bound α-synuclein provides insight into the MoA of the anti-Parkinson drug UCB0599
α-synuclein (αS) is an intrinsically disordered protein whose functional ambivalence and protein structural plasticity are iconic. Coordinated protein recruitment ensures proper vesicle dynamics at the synaptic cleft, while deregulated oligomerization on cellular membranes contributes to cell damage...
Autores principales: | Schwarz, Thomas C., Beier, Andreas, Ledolter, Karin, Gossenreiter, Thomas, Höfurthner, Theresa, Hartl, Markus, Baker, Terry S., Taylor, Richard J., Konrat, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104497/ https://www.ncbi.nlm.nih.gov/pubmed/37027427 http://dx.doi.org/10.1073/pnas.2201910120 |
Ejemplares similares
-
Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α‐Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease
por: Smit, Johan Willem, et al.
Publicado: (2022) -
Open MoA: revealing the mechanism of action (MoA) based on network topology and hierarchy
por: Liao, Xinmeng, et al.
Publicado: (2023) -
Magnetoresistance and robust resistivity plateau in MoAs(2)
por: Wang, Jialu, et al.
Publicado: (2017) -
Computational analyses of mechanism of action (MoA): data, methods and integration
por: Trapotsi, Maria-Anna, et al.
Publicado: (2021) -
Electronic structure and topological properties of centrosymmetric MoAs(2)/WAs(2) from first principles
por: Chen, Jia, et al.
Publicado: (2017)